A History of Systemic Hypertension and Incident Heart Failure Hospitalization in Patients With Acute Myocardial Infarction and Left Ventricular Systolic Dysfunction

American Journal of Cardiology

Volumn 103, Issue 10, 2009, Pages 1374-1380

  Ahmed, Ali ^a,b   Pitt, Bertram ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; MAGNESIUM; NITRIC ACID DERIVATIVE; POTASSIUM;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SYMPTOM;

AGED; ALDOSTERONE ANTAGONISTS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SPIRONOLACTONE; SURVIVAL ANALYSIS;

EID: 65449132745     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.01.347     Document Type: Article

References (31)

1. Pfeffer M.A., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
2. Gottdiener J.S., Arnold A.M., Aurigemma G.P., Polak J.F., Tracy R.P., Kitzman D.W., Gardin J.M., Rutledge J.E., and Boineau R.C. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35 (2000) 1628-1637
3. Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., Vargiu P., Simongini I., and Laragh J.H. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19 (1992) 1550-1558
4. Kamimori K., Yoshiyama M., Shimada Y., Iida H., Nakamura Y., Uchida E., Yoshida K., Jissho S., Fukuda S., Takeuchi K., and Yoshikawa J. Antecedent hypertension interacts with adverse ventricular remodeling after myocardial infarction. Osaka City Med J 50 (2004) 53-59
5. Parodi G., Carrabba N., Santoro G.M., Memisha G., Valenti R., Buonamici P., Dovellini E.V., and Antoniucci D. Heart failure and left ventricular remodeling after reperfused acute myocardial infarction in patients with hypertension. Hypertension 47 (2006) 706-710
6. Pitt B., Remme W., Zannad F., Neaton J., Martinez F., Roniker B., Bittman R., Hurley S., Kleiman J., and Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
7. Rosenbaum P.R., and Rubin D.B. The central role of propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
8. Rubin D.B. Using propensity score to help design observational studies: Application to the tobacco litigation. Health Serv Outcomes Res Methodol 2 (2001) 169-188
9. Ahmed A., Rich M.W., Sanders P.W., Perry G.J., Bakris G.L., Zile M.R., Love T.E., Aban I.B., and Shlipak M.G. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 99 (2007) 393-398
10. Ahmed A., Zannad F., Love T.E., Tallaj J., Gheorghiade M., Ekundayo O.J., and Pitt B. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28 (2007) 1334-1343
11. Ahmed A., Husain A., Love T.E., Gambassi G., Dell'Italia L.J., Francis G.S., Gheorghiade M., Allman R.M., Meleth S., and Bourge R.C. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27 (2006) 1431-1439
12. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
13. Normand S.T., Landrum M.B., Guadagnoli E., Ayanian J.Z., Ryan T.J., Cleary P.D., and McNeil B.J. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54 (2001) 387-398
14. Kannel W.B., Sorlie P., and McNamara P.M. Prognosis after initial myocardial infarction: the Framingham study. Am J Cardiol 44 (1979) 53-59
15. Herlitz J., Waagstein F., Lindqvist J., Swedberg K., and Hjalmarson A. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial). Am J Cardiol 80 suppl (1997) 40J-44J
16. Kannel W.B., Sorlie P., Castelli W.P., and McGee D. Blood pressure and survival after myocardial infarction: the Framingham study. Am J Cardiol 45 (1980) 326-330
17. Thune J.J., Signorovitch J., Kober L., Velazquez E.J., McMurray J.J., Califf R.M., Maggioni A.P., Rouleau J.L., Howlett J., Zelenkofske S., et al. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension 51 (2008) 48-54
18. Lloyd-Jones D.M., Larson M.G., Leip E.P., Beiser A., D'Agostino R.B., Kannel W.B., Murabito J.M., Vasan R.S., Benjamin E.J., and Levy D. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106 (2002) 3068-3072
19. Solomon S.D., Janardhanan R., Verma A., Bourgoun M., Daley W.L., Purkayastha D., Lacourciere Y., Hippler S.E., Fields H., Naqvi T.Z., et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 369 (2007) 2079-2087
20. Ahmed A., Perry G.J., and Husain A. VALIDD should not invalidate angiotensin-receptor blockers. Lancet 369 (2007) 2053-2054
21. Chen-Izu Y., Chen L., Banyasz T., McCulle S.L., Norton B., Scharf S.M., Agarwal A., Patwardhan A., Izu L.T., and Balke C.W. Hypertension-induced remodeling of cardiac excitation-contraction coupling in ventricular myocytes occurs prior to hypertrophy development. Am J Physiol Heart Circ Physiol 293 (2007) H3301-H3310
22. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M.L., Konstam M.A., Mancini D.M., Michl K., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). http://www.acc.org/clinical/guidelines/failure/index.pdf Accessed August 17, 2005
23. Rothwell P.M. Treating Individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365 (2005) 176-186
24. Pitt B., Ahmed A., Love T.E., Krum H., Nicolau J., Cardoso J.S., Parkhomenko A., Aschermann M., Corbalán R., Solomon H., et al. History of hypertension and the effects of eplerenone in patients with acute myocardial infarction complicated by systolic heart failure. Hypertension 52 (2008) 271-278
25. Kenchaiah S., Pfeffer M.A., St. John Sutton M., Plappert T., Rouleau J.L., Lamas G.A., Sasson Z., Parker J.O., Geltman E.M., and Solomon S.D. Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial). Am J Cardiol 94 (2004) 1-8
26. Fresco C., Avanzini F., Bosi S., Franzosi M.G., Maggioni A.P., Santoro L., Bellanti G., and GISSI-2 Investigators. Prognostic value of a history of hypertension in 11,483 patients with acute myocardial infarction treated with thrombolysis. J Hypertens 14 (1996) 743-750
27. Doughty R.N., Whalley G.A., Walsh H.A., Gamble G.D., Lopez-Sendon J., and Sharpe N. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 109 (2004) 201-206
28. Hayashi M., Tsutamoto T., Wada A., Tsutsui T., Ishii C., Ohno K., Fujii M., Taniguchi A., Hamatani T., Nozato Y., et al. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation 107 (2003) 2559-2565
29. van Kats J.P., Duncker D.J., Haitsma D.B., Schuijt M.P., Niebuur R., Stubenitsky R., Boomsma F., Schalekamp M.A., Verdouw P.D., and Danser A.H. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 102 (2000) 1556-1563
30. Yoshiyama M., Omura T., and Yoshikawa J. Additive improvement of left ventricular remodeling by aldosterone receptor blockade with eplerenone and angiotensin II type 1 receptor antagonist in rats with myocardial infarction. Nippon Yakurigaku Zasshi 124 (2004) 83-89
31. Clarke R., Shipley M., Lewington S., Youngman L., Collins R., Marmot M., and Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150 (1999) 341-353